LYNDRA THERAPEUTICS

lyndra-therapeutics-logo

Lyndra Therapeutics is reinventing medicines to make daily pills a thing of the past, replacing them with its oral, ultra-long-acting, sustained-release therapies. Administering and conveniently distributing medicines in weekly or longer-term doses – including using polypill approaches – will improve safety, efficacy, and adherence to maximize global health impact and lower overall healthcare costs.

#SimilarOrganizations #People #Financial #Event #Website #More

LYNDRA THERAPEUTICS

Social Links:

Industry:
Biotechnology Clinical Trials Health Care Pharmaceutical

Founded:
2015-01-14

Address:
Watertown, Massachusetts, United States

Country:
United States

Website Url:
http://www.lyndra.com

Total Employee:
11+

Status:
Active

Contact:
+1-857-304-4512

Email Addresses:
[email protected]

Total Funding:
163.33 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins


Similar Organizations

novabay-pharmaceuticals-logo

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.


Current Advisors List

giovanni-traverso_image

Giovanni Traverso Co-founder & Member of the Board of Directors @ Lyndra Therapeutics
Board_member
2015-01-01

catherine-b-reynolds_image

Catherine B. Reynolds Chairwoman of the Board of Directors @ Lyndra Therapeutics
Board_member
2016-01-01

amy-schulman_image

Amy Schulman Member of the Board of Directors @ Lyndra Therapeutics
Board_member
2015-01-01

zafrira-avnur_image

Zafrira Avnur Member of the Board of Directors @ Lyndra Therapeutics
Board_member
2016-01-01

robert-langer_image

Robert Langer Member of the Board of Directors @ Lyndra Therapeutics
Board_member
2015-01-01

Current Employees Featured

amy-schulman_image

Amy Schulman
Amy Schulman Executive Chairman & Co-Founder @ Lyndra Therapeutics
Executive Chairman & Co-Founder
2015-01-01

raymond-knox_image

Raymond Knox
Raymond Knox Chief Manufacturing Officer @ Lyndra Therapeutics
Chief Manufacturing Officer
2016-11-01

klas-holmlund_image

Klas Holmlund
Klas Holmlund Chief Financial Officer @ Lyndra Therapeutics
Chief Financial Officer
2021-12-01

stephen-zale_image

Stephen Zale
Stephen Zale Scientific Fellow @ Lyndra Therapeutics
Scientific Fellow
2016-11-01

jessica-ballinger_image

Jessica Ballinger
Jessica Ballinger COO @ Lyndra Therapeutics
COO
2016-10-01

patricia-hurter_image

Patricia Hurter
Patricia Hurter CEO, President & Board Member @ Lyndra Therapeutics
CEO, President & Board Member
2019-09-01

orn-almarsson_image

Orn Almarsson
Orn Almarsson Chief Technology Officer @ Lyndra Therapeutics
Chief Technology Officer
2020-05-01

ray-knox_image

Ray Knox
Ray Knox Chief Engineering Officer @ Lyndra Therapeutics
Chief Engineering Officer
2018-01-01

not_available_image

Tyler Grant
Tyler Grant Senior Director of Engineering @ Lyndra Therapeutics
Senior Director of Engineering
2020-01-01

richard-scranton_image

Richard Scranton
Richard Scranton Chief Medical Officer @ Lyndra Therapeutics
Chief Medical Officer
2020-01-01

Founder


amy-schulman_image

Amy Schulman

andrew-bellinger_image

Andrew Bellinger

colin-r-gardner_image

Colin R. Gardner

giovanni-traverso_image

Giovanni Traverso

robert-langer_image

Robert Langer

Investors List

aig-investments_image

AIG Investments

AIG Investments investment in Series C - Lyndra Therapeutics

limitless-ventures_image

Limitless Ventures

Limitless Ventures investment in Series C - Lyndra Therapeutics

gilead-sciences_image

Gilead Sciences

Gilead Sciences investment in Series C - Lyndra Therapeutics

impactassets_image

ImpactAssets

ImpactAssets investment in Series C - Lyndra Therapeutics

quark-venture_image

Quark Venture

Quark Venture investment in Series C - Lyndra Therapeutics

yipinhong-pharmacy_image

Yipinhong Pharmacy

Yipinhong Pharmacy investment in Series C - Lyndra Therapeutics

the-catalytic-impact-foundation-cif_image

THE CATALYTIC IMPACT FOUNDATION (CIF)

THE CATALYTIC IMPACT FOUNDATION (CIF) investment in Series C - Lyndra Therapeutics

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series C - Lyndra Therapeutics

hopu-fund_image

HOPU Investment Management Company

HOPU Investment Management Company investment in Series C - Lyndra Therapeutics

mass-general-brigham-ventures_image

Mass General Brigham Ventures

Mass General Brigham Ventures investment in Series C - Lyndra Therapeutics

Key Employee Changes

Date New article
2021-12-08 Lyndra Therapeutics Appoints Klas Holmlund, CFA, as Chief Financial Officer

Official Site Inspections

http://www.lyndra.com Semrush global rank: 3.54 M Semrush visits lastest month: 4.13 K

  • Host name: 141.193.213.21
  • IP address: 141.193.213.21
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Lyndra Therapeutics"

Lyndra Therapeutics - Crunchbase Company Profile

Lyndra Therapeutics is a company that develops medicines for long-term drug …See details»

Lyndra Company Profile - Office Locations, Competitors, Revenue …

Lyndra has 5 employees across 2 locations and $151.83 m in total funding,. See insights on Lyndra including office locations, competitors, revenue, financials, executives, subsidiaries and …See details»

Lyndra Therapeutics, Inc. | Re-Imagining TB Care

Lyndra is a private US-based specialty pharma company seeks to improve healthcare outcomes through oral, ultra-long-acting, sustained-release therapies that change how people take …See details»

Lyndra Therapeutics, Inc. - CMOCRO

Lyndra Therapeutics is pioneering long-acting oral therapies, the most significant advance in oral drug delivery in decades. Lyndra’s proprietary drug delivery platform delivers medicine for a …See details»

Lyndra Therapeutics, Inc. - Drug pipelines, Patents, …

May 7, 2025 Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill …See details»

Lyndra Therapeutics 2025 Company Profile: Valuation, …

Information on valuation, funding, cap tables, investors, and executives for Lyndra Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

Lyndra Therapeutics

Lyndra’s technology has the potential for broad applicability across multiple therapeutic areas - including approved drugs and those currently in development. This includes programs for …See details»

Lyndra Therapeutics - The Org

Lyndra Therapeutics is pioneering the first-ever oral, ultra-long-acting, sustained-release therapies, which have the potential to fundamentally change the way …See details»

Langer spinout Lyndra begins winding down

Mar 27, 2025 Lyndra Therapeutics, which spun out of Moderna co-founder Robert Langer’s lab at the Massachusetts Institute of Technology in 2015, is …See details»

Lyndra, Inc. - Executive Bio, Top Executies, and Transitions - Equilar ...

Lyndra Therapeutics is a clinical-stage biopharmaceutical company partnering to create and commercialize long-acting oral therapies. Lyndra’s LYNX® drug delivery platform delivers …See details»

Lyndra Therapeutics, Inc. - Devex

Learn more about Lyndra Therapeutics, Inc.'s jobs, projects, latest news, contact information and geographical presence. TRANSFORMING THE WAY THEY TAKE MEDICINE FOR A …See details»

Lyndra Therapeutics Announces Leadership Changes, Update on

Jul 17, 2023 Lyndra Therapeutics today announced long-time Lyndra executive President and Chief Operations Officer Jessica Ballinger has been appointed President and CEO.See details»

About LYNDRA THERAPEUTICS | DxMultiomics

Jan 4, 2024 Lyndra Therapeutics is a clinical-stage biopharmaceutical company pioneering long-acting oral therapies. Lyndra’s LYNX® drug delivery platform is one of the most significant …See details»

A day in the life of a pharma exec: Lyndra’s Patricia Hurter

May 17, 2023 In focus with: Patricia Hurter, CEO and board member, Lyndra Therapeutics The lowdown on Lyndra: Rather than innovating new drugs, Lyndra is aiming to dramatically …See details»

Lyndra Therapeutics Announces Strategic Clinical Research and ...

Jan 15, 2025 Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced a strategic collaboration withSee details»

7 questions for 7 years at Lyndra - LinkedIn

Sep 14, 2022 At Lyndra, the great leaders lead authentically. They open up, share personal stories, show vulnerability and take the time to meet with individuals at all levels of the …See details»

Lyndra - 2025 Company Profile & Team - Tracxn

Jun 24, 2025 Lyndra is a deadpooled company based in Cambridge (United States), founded in 2015 by C Giovanni Traverso, Amy Schulman, Andrew Bellinger and Robert Langer. It …See details»

About - Lyndra

Lyndra Therapeutics is pioneering long-acting oral therapies, a potential major advance in oral drug delivery. Lyndra’s proprietary LYNXâ„¢ drug delivery platform is designed to deliver …See details»

Research - Lyndra

Lyndra is reinventing medicine for a healthier world with the help of its partners and with funding support from organizations including the Bill & Melinda Gates Foundation, the National …See details»

Contact - Lyndra

We'd love to hear from you. Contact Lyndra today to learn about partnerships, investment opportunities, research or general questions.See details»

linkstock.net © 2022. All rights reserved